Detailed price information for Nrx Pharmaceuticals Inc (NRXP-Q) from The Globe and Mail including charting and trades.

RADNOR, Pa., July 1, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that the Company ...

Remaining $5.4 million debt was repaid through strategic equity conversion in common stock with no additional warrants or adjustment ...

Detailed price information for Nrx Pharmaceuticals Inc (NRXP-Q) from The Globe and Mail including charting and trades.

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

Nrx Pharmaceuticals, Inc. ((NRXP)) has held its Q3 earnings call. Read on for the main highlights of the call. The recent earnings call for NRx Pharmaceuticals, Inc. painted a picture of optimism and ...

RADNOR, Pa. and WEST COLUMBIA, S.C., Nov. 6, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", (NRx), a clinical-stage ...

-- 50% reduction in corporate overhead and 25% reduction in overall net loss in 2023, compared to 2024 with $0.20 per share improvement in negative earnings. Additions to working capital of $8 million ...

NRX Pharmaceuticals (NASDAQ:NRXP) shares are trading higher on Thursday after the company’s Hope Therapeutics subsidiary announced the planed acquisition of Kadima Neuropsychiatry Institute. The ...

RADNOR, Pa., Aug. 14, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals (NRXP)", the "Company"), a clinical-stage biopharmaceutical company, today announced its ...

NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal ...